Authors

Latest:

Tusamitamab Ravtansine Plus Ramucirumab as 2L Therapy or Beyond in Patients With Metastatic NSq NSCLC and High CEACAM5 Expression (CARMEN-LC04)

Grace Dy, MD, presents data from the CARMEN-LC04 study evaluating safety and anti-tumor activity of tusamitamab ravtansine combined with ramucirumab in high CEACAM5-expressing non-squamous cell (NSQ) NSCLC tumors.

Memorial Sloan Kettering Cancer Center

Latest:

Memorial Sloan Kettering Cancer Center Launches MSKCC India to Expand Access to World-Renowned Oncologists, Cancer Care, Research, and Education

Memorial Sloan Kettering Cancer Center, the world’s oldest and largest private cancer center, has launched MSKCC India to provide cancer patients in India with access to the institution’s world-renowned oncologists, research, clinical trials, and education.

Rachel Zeig-Owens, DrPH, MPH

Latest:

New Cancer Study Results Confirm Lasting Effects on 9/11 First Responders

Research investigating the physical and mental health consequences of being at the World Trade Center site during and after the terrorist attacks has been instrumental in obtaining health care coverage for thousands of individuals.

Brittany F. Lees, MD

Latest:

Dr. Lees on the Utility of Genetic Testing in Ovarian Cancer

Brittany F. Lees, MD, discusses the utility of genetic and genomic testing in ovarian cancer.

Renee Saliby, MD

Latest:

Dr Saliby on the Correlation Between Intermediate End Points and OS in RCC

Renee Saliby, MD, MSc, discusses the investigation of the correlation between intermediate end points and OS in metastatic renal cell carcinoma.

Pratibha Binder, MD

Latest:

Dr. Binder on the Use of Immune Checkpoint Inhibitors in Endometrial Cancer Treatment

Pratibha Binder, MD, discusses how the introduction of novel immune checkpoint inhibitors into frontline treatment strategies could ameliorate unmet needs in endometrial cancer.

Peter Schmid, FRCP, MD, PhD

Latest:

Schmid Summarizes Updates in HER2-Positive Breast Cancer Management

Dr Schmid discusses considerations for applying recent data updates in HER2-positive breast cancer management to clinical practice.

Mylin A. Torres, MD

Latest:

Dr Torres on Treatment With ADCs in Breast Cancer

Mylin A. Torres, MD, discusses using antibody-drug conjugates (ADCs) to treat patients with breast cancer.

Alessandro Gronchi, MD

Latest:

Dr. Gronchi on the Results of the TRASTS Trial in Soft Tissue Sarcoma

Alessandro Gronchi, MD, discusses the results of the phase 2 TRASTS trial in soft tissue sarcoma.

Daniel Keifenheim, PhD

Latest:

Novel Tubulin-Targeting Therapies Make Headway

Clinical findings have recently been reported for 2 of the more advanced emerging tubulin-targeting agents, VERU-111 and plinabulin.

Tim Cortese

Latest:

T-DM1 Is Not Associated With Improved PFS vs Historical Controls in Pretreated HER2+ Biliary Tract Cancer

T-DM1 was found to be tolerable, but progression-free survival was not improved vs historical data in HER2-positive biliary tract cancer.

Kent Hoskins, MD

Latest:

Dr. Hoskins on the Impact of Race on Breast Cancer Outcomes

Kent Hoskins, MD, discusses the impact of race on breast cancer outcomes.

Emily C. Ayers, MD

Latest:

Dr. Ayers on the Evolving Treatment Landscape in CLL

Emily C. Ayers, MD, hematologist/oncologist, assistant professor, University of Virginia Health, discusses the evolving treatment landscape in chronic lymphocytic leukemia.

Eleonora Dondossola, PhD

Latest:

Dr Dondossola on the Importance of Studying Bone Metastasis in RCC

Eleonora Dondossola, PhD, discusses the importance of studying bone metastasis in RCC and other genitourinary cancers.

Brian C. Grieb, MD, PhD

Latest:

Dr Grieb on the Need for Novel Biomarkers in CRC

Brian C. Grieb, MD, PhD, discusses unmet needs for patients with colorectal cancer, including the identification of novel pan-CRC biomarkers for drug development.

Jeffrey Laurence, MD, Weill Cornell Medicine

Latest:

Narsoplimab Trial Results

The panel of transplant experts discuss the results of the phase 2 trial of narsoplimab and the pending FDA approval of this agent for treatment of transplant-associated of thrombotic microangiopathy.

John P. Sfakianos, MD

Latest:

Dr. Sfakianos on Importance of Restaging Transurethral Resection of Bladder Tumors

John P. Sfakianos, MD, discusses the importance of restaging transurethral resection of bladder tumors.

Aatur D. Singhi, MD, PhD

Latest:

Dr. Singhi on the Importance of Multidisciplinary Care With Pathologists in Cancer

Aatur D. Singhi, MD, PhD, discusses the importance of facilitating multidisciplinary conversations that include pathologists in cancer care.

Asim V. Farooq, MD, University of Chicago Medical Center

Latest:

Influencing Factors to Initially Targeting BCMA in MM

Geoffrey Shouse, DO, PhD

Latest:

Dr Shouse on the Importance of NGS Testing in Follicular Lymphoma

Geoffrey Shouse, DO, PhD, discusses the importance of performing next-generation sequencing in patients with follicular lymphoma.